Medicine, Rheumatology Division

Grants

Grants per year 1993 2002 2007 2008 2010 2011 2013 2014 2015 2016 2017 2018 2019 2020 2021 2027

• 1 Not started
• 76 Active
• 356 Finished

Grants per year

Search results

• DNA Microarray and Traditional SSc Biomarkers: Does Microarray Provide Additional Prognostic Information?

  Hinchcliff, M. E., Agrawal, R., Lee, J. & Perlman, H. R.

  Scleroderma Research Foundation

  9/1/11 → 4/30/18

  Project: Research project

• NIAMS: Core Center - Proteomics and Clinical Core

  Varga, J., Goncalves Marangoni, R. & Hinchcliff, M. E.

  Boston University, National Institute of Arthritis and Musculoskeletal and Skin Diseases

  9/1/11 → 8/31/16

  Project: Research project

• Fatigue and Lifestyle Physical Activity in SLE

  Ramsey-Goldman, R., Chmiel, J. S., Dunlop, D. D. & Yount, S.

  National Institute of Arthritis and Musculoskeletal and Skin Diseases

  9/1/11 → 8/31/13

  Project: Research project

• Prot# MA25522: A Randomized, Double-Blind, Parallel-Group Study Of The Reduction Of Signs And Symptoms During Treatment With Tocilizumab Versus Adalimumab, Both In Combination With MTX, In Patients With Moderate To Severe Active Rheumatoid Arthritis And A

  Ruderman, E. M.

  PharmaNet, Inc., Genentech, Inc.

  9/6/11 → 9/6/14

  Project: Research project

• Scleroderma Subtyping from Fresh and Archived Biopsies Using NextGen Sequencing

  Hinchcliff, M. E. & Varga, J.

  Celdara Medical, LLC, National Institute of Arthritis and Musculoskeletal and Skin Diseases

  9/6/11 → 9/5/13

  Project: Research project

• Core C - Perlman

  Perlman, H. R.

  National Heart, Lung, and Blood Institute

  9/7/11 → 4/30/16

  Project: Research project

  • Stem Cells 100%
  • Endothelial Progenitor Cells 99%
  • Cell- and Tissue-Based Therapy 77%
  • Ischemia 61%
  • erucylphosphocholine 40%

• Cardiovascular Regenerative Medicine

  Vaughan, D. E., Ardehali, H., Eren, M., Ghosh, A. K., Kume, T., Meade, T. J., Perlman, H. R., Schumacker, P. T., Stupp, S., Vaughan, D. E. & Wasserstrom, J. A.

  National Heart, Lung, and Blood Institute

  9/7/11 → 4/30/16

  Project: Research project

  • Regenerative Medicine 100%
  • Stem Cells 95%
  • Endothelial Progenitor Cells 95%
  • Cell- and Tissue-Based Therapy 74%
  • Ischemia 58%

• Prot# GHO-09-1621: Lupus Impact Tracker: A Longitudinal Validation Study

  Ramsey-Goldman, R. & Hsieh, C.

  Kendle International Inc., GlaxoSmithKline LLC

  9/14/11 → 9/14/14

  Project: Research project

• Signaling in the Lung Induced by Particulate Matter Air Pollution

  Budinger, G. S. & Perlman, H. R.

  National Institute of Environmental Health Sciences

  9/19/11 → 4/30/16

  Project: Research project

  • Particulate Matter 100%
  • Air Pollution 87%
  • Interleukin-6 84%
  • Interleukin-8B Receptors 65%
  • Alveolar Macrophages 61%

• Research in Field of Arthritis

  Pope, R. M.

  Hoellen Family Foundation

  11/1/11 → 5/31/12

  Project: Research project

• Prot# A 9391010: A Phase 2, Randomized, Double-Blind Assessment of Efficacy and Safety of PF-04171327(1, 5, 10, 15 MG Dose, Daily) Compared to 5 MG and 10 MG Prednisone Daily and Placebo Daily in Subjects with Rheumatoid Arthritis Over an 8 Week Period Fo

  Ruderman, E. M.

  Pfizer Inc.

  11/8/11 → 11/8/14

  Project: Research project

• Prot# SL0010: A Phase 3, Randomized, Double-Blind, Placebo Controlled, Multicenter Study of The Efficacy and Safety of four 12-week Treatment Cycles (48 weeks total) Of Epratuzumab in Systematic Lupus Erythematosus Subjects With Moderate To Severe Disease

  Hsieh, C.

  Parexel, UCB Biosciences, Inc.

  12/13/11 → 12/13/14

  Project: Research project

• Prot#11-216: Treating to Target (T2T) for Patients with Rheumatoid Arthritis in a US Population: Outcomes and Feasibility

  Ruderman, E. M.

  Corrona, LLC

  1/19/12 → 1/19/15

  Project: Research project

• Prot#SL0012: A Phase 3, Multicenter, Open-Label, Extension Study to Assess the Safety and Tolerability Of Epratuzumab Treatment in Systemic Lupus Erythematosus Subjects (EMBODY 4)

  Hsieh, C.

  Parexel, UCB Biosciences, Inc.

  5/18/12 → 5/18/15

  Project: Research project

• Preceptorship for Luke Barr in support of: International Registry for Biologics in Systemic Lupus Erythematosus (IRBIS)

  Ramsey-Goldman, R.

  Rheumatology Research Foundation

  5/28/12 → 6/30/13

  Project: Research project

• Postdoctoral Rheumatology Training

  Pope, R. M., Chang, R. W., Datta, S. K. & Ramsey-Goldman, R.

  National Institute of Arthritis and Musculoskeletal and Skin Diseases

  7/1/12 → 6/30/16

  Project: Research project

• ACRREF Rheumatology Scientist Development Award for Shawn Rose in support of: A Novel Mouse Model of Atherosclerosis in Inflammatory Arthritis

  Perlman, H. R.

  Rheumatology Research Foundation

  7/1/12 → 10/31/12

  Project: Research project

• Cancer Risk After Renal Transplant in Autoimmune Disease

  Ramsey-Goldman, R.

  National Cancer Institute

  7/6/12 → 6/30/14

  Project: Research project

• Unconventional APC Inducing Autoimmune Th17 Cell Expansion in Lupus

  Datta, S. K., Zhang, L. & Zhang, L.

  National Institute of Allergy and Infectious Diseases

  8/1/12 → 8/31/15

  Project: Research project

• Postdoctoral Fellowship for Sonal Khare in Support of: POP3: A Novel Inhibitor of Inflammatory Arthritis

  Stehlik, C. & Khare, S.

  Arthritis Foundation

  9/1/12 → 8/31/13

  Project: Research project

• Eliminating Lupus Health Disparities Initiative (ELHDI)

  Ramsey-Goldman, R.

  American College of Rheumatology, Department of Health and Human Services

  9/1/12 → 8/31/14

  Project: Research project

• Knee OA: Predictors and Outcomes of Physical Inactivity-Activity Transitions

  Dunlop, D. D., Chang, R. W., Lee, J. & Sharma, L.

  National Institute of Arthritis and Musculoskeletal and Skin Diseases

  9/1/12 → 8/31/16

  Project: Research project

• Mechanisms of Airborne Particulate Matter Induced Thrombosis

  Budinger, G. S., Chandel, N., Green, D. & Perlman, H. R.

  National Institute of Environmental Health Sciences

  9/14/12 → 5/1/14

  Project: Research project

• Aberrant Recapitulation of Developmental Program: Novel Target in Scleroderma

  Varga, J., Gottardi, C., Hinchcliff, M. E. & Wei, J.

  U.S. Army Medical Research and Materiel Command

  9/30/12 → 3/31/16

  Project: Research project

• Prot #CC-10004-AS-001: A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Apremilast (CC-10004) in the Treatment of Active Ankylosing Spondylitis

  Ruderman, E. M.

  PPD Development, Celgene Corporation

  10/23/12 → 10/23/15

  Project: Research project